Keystone Heart to Accelerate Trials for a New Advanced Cerebral Embolic Protection Device Post author:Sam Post published:August 1, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like SteadyMed Announces FDA Agreed Pathway to Trevyent NDA Resubmission December 7, 2017 Rejected Again: Ablynx Turns Down Novo Nordisk's Sweetened $3.1B Bid January 7, 2018 It's Official: Ovid CEO Just Filed for $86 Million IPO April 11, 2017